Abstract: The present disclosure relates to a method of diagnosing colorectal neoplasm, screening for the onset or risk to the onset of colorectal neoplasm or assessing the development or prognosis of colorectal neoplasm in a subject, a method of monitoring treatment response in a subject who is receiving treatment of colorectal neoplasm, and a kit for using in the methods.
Type:
Application
Filed:
March 1, 2021
Publication date:
June 22, 2023
Applicant:
SINGLERA HEALTH TECHNOLOGIES (SHANGHAI) LTD.